Jay Wish MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for outpatient dialysis at Indiana University Health, discusses the challenges of maintaining healthy phosphorus levels in patients. Hyperphosphatemia, or an electrolyte disorder in which there is an elevated level of phosphate in the blood, can cause serious cardiac conditions. In this episode, he discusses the current challenges in care, his recent peer-reviewed data on phosphate management and the latest research on potential new solutions on the horizon for CKD patients in need. This discussion comes just ahead of ASN’s Kidney Week where there will be new data on the impact of hyperphosphatemia on CKD patients and potential new treatments.
Jay B. Wish, MD is Medical Director of the Out-Patient Dialysis Unit at Indiana University Hospital, Chief Medical Officer for Dialysis at IU Health, and Professor of Clinical Medicine at Indiana University School of Medicine. He is past president of the National Forum of ESRD Networks and was the lead nephrology consultant to the Fistula First Breakthrough Initiative 2009-2012. He served on the Board of Directors of the Renal Physicians Association and the American Association of Kidney Patients and was the recipient of the latter’s Visionary Award in 2005. Dr. Wish is Vice Chairman of the Editorial Advisory Board for Nephrology News & Issues and is on the editorial boards of the Clinical Journal of the American Society of Nephrology and the Journal of the American Society of Nephrology. He has had numerous articles, editorials, reviews, and book chapters published, particularly in the areas of End-Stage Kidney Disease quality oversight/improvement, accountability, anemia management and vascular access.